发明名称 Human thrombopoietin comprising glycosylation sited at residues 157 and 164
摘要 The present invention relates to novel human thrombopoietin (hTPO) derivatives, and to process of preparation thereof. Particularly, sugar chains are introduced into native hTPO by substituting amino acids such as asparagine for amino acids at specific positions in native hTPO, preparing novel hTPO derivatives with high activities enhancing the platelet production in vivo. Therefore, the novel hTPO derivatives of this invention may be useful for the treatment of thrombocytopenia associated with anticancer therapy or the transplantation of bone marrow.
申请公布号 US7037491(B2) 申请公布日期 2006.05.02
申请号 US20050043387 申请日期 2005.01.26
申请人 DAEWOONG PHARMACEUTICAL CO., LTD. 发明人 CHUNG JOO YOUNG;PARK SANG KYU;JU SANG MYOUNG;AHN HYEA KYUNG;LIM SEUNG WOOK;CHANG WOO IK;PARK SEUNG KOOK;KOH YEO WOOK;PARK JI SOO
分类号 C07K14/52 主分类号 C07K14/52
代理机构 代理人
主权项
地址